$74.42
-2.54 (-3.30%)
Performance
1D
—
1W
—
1M
—
3M
-8.48%
6M
+32.30%
1Y
+133.88%
YTD
+2.28%
Open$75.67
Previous Close$76.96
Day High$76.01
Day Low$73.31
52W High$103.00
52W Low$19.45
Volume—
Avg Volume813.4K
Market Cap6.83B
P/E Ratio—
EPS$-3.59
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$78.66
Below
SMA 200
$56.03
Above
RSI (14)
77.3
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
29 analysts
Price Target
-58.3% upside
Current
$74.42
$74.42
Target
$31.03
$31.03
$20.33
$31.03 avg
$33.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 50.82M | 58.78M | 7.83B |
| Net Income | -241,650,965 | -251,545,071 | 335.40M |
| Profit Margin | -475.6% | -451.8% | 4.3% |
| EBITDA | -274,475,963 | -301,587,051 | 592.59M |
| Free Cash Flow | — | — | 369.62M |
| Rev Growth | -13.5% | -13.5% | +18.7% |
| Debt/Equity | 0.00 | 0.00 | 0.53 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |